{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:13:12Z","timestamp":1791281592459,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T00:00:00Z","timestamp":1372809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s40273-013-0070-5","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T01:50:21Z","timestamp":1372729821000},"page":"767-780","source":"Crossref","is-referenced-by-count":20,"title":["Smoking Cessation Treatment and Outcomes Patterns Simulation: A New Framework for Evaluating the Potential Health and Economic Impact of Smoking Cessation Interventions"],"prefix":"10.1007","volume":"31","author":[{"given":"Denis","family":"Getsios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen\u0151 P.","family":"Marton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Revankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Willke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Rublee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Jack","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Xenakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,3]]},"reference":[{"key":"70_CR1","first-page":"300","volume":"14","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","unstructured":"Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs\u2014United States, 1995\u20131999. MMWR Morb Mortal Wkly Rep. 2002;14:300\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"70_CR2","first-page":"29","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC). State-specific smoking-attributable mortality and years of potential life lost\u2014United States, 2000\u20132004. MMWR Morb Mortal Wkly Rep. 2009;58(2):29\u201333.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"70_CR3","first-page":"889","volume":"61","author":"I Agaku","year":"2012","unstructured":"Agaku I, King B, Dube SR. Current cigarette smoking among adults \u2013 United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(44):889\u201394.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"70_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","volume":"99","author":"JR Hughes","year":"2004","unstructured":"Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29\u201338.","journal-title":"Addiction"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"iii83","DOI":"10.1136\/tc.2005.013516","volume":"15 Suppl. 3","author":"A Hyland","year":"2006","unstructured":"Hyland A, Borland R, Li Q, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 Suppl. 3:iii83\u201394.","journal-title":"Tob Control"},{"issue":"Suppl. 2","key":"70_CR6","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1136\/tc.6.suppl_2.S57","volume":"6","author":"N Hymowitz","year":"1997","unstructured":"Hymowitz N, Cummings KM, Hyland A, et al. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control. 1997;6(Suppl. 2):S57\u201362.","journal-title":"Tob Control"},{"key":"70_CR7","unstructured":"Fiore M, Jaen C, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Rockville: US Department of Health and Human Services, US Public Health Service; 2008"},{"issue":"1","key":"70_CR8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/ijerph8010222","volume":"8","author":"BV Fix","year":"2011","unstructured":"Fix BV, Hyland A, Rivard C, et al. Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006\u20132008 International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health. 2011;8(1):222\u201333.","journal-title":"Int J Environ Res Public Health"},{"key":"70_CR9","unstructured":"Chantix U.S. Consumer Attitudes, Trends, and Usage Research\u2014Wave 8 Report\u2014April 2010; conducted by Opinion Research Corporation Guideline, Inc., Princeton NJ and Pfizer, Inc. New York (data on file)"},{"issue":"10","key":"70_CR10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1742-1241.2011.02758.x","volume":"65","author":"K Yeomans","year":"2011","unstructured":"Yeomans K, Payne KA, Marton JP, et al. Smoking, smoking cessation and smoking relapse patterns: a web-based survey of current and former smokers in the US. Int J Clin Pract. 2011;65(10):1043\u201354.","journal-title":"Int J Clin Pract"},{"issue":"Suppl. 2","key":"70_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1360-0443.2005.01028.x","volume":"100","author":"J Ferguson","year":"2005","unstructured":"Ferguson J, Bauld L, Chesterman J, et al. The English smoking treatment services: one-year outcomes. Addiction. 2005;100(Suppl. 2):59\u201369.","journal-title":"Addiction"},{"key":"70_CR12","unstructured":"Fiore M, Ja\u00e9n C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Quick reference guide for clinicians. Rockville: US Department of Health and Human Services, US Public Health Service; 2009"},{"issue":"7","key":"70_CR13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/11590120-000000000-00000","volume":"30","author":"K Bolin","year":"2012","unstructured":"Bolin K. Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models. Pharmacoeconomics. 2012;30(7):551\u201364.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"70_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10198-006-0362-1","volume":"7","author":"KR Olsen","year":"2006","unstructured":"Olsen KR, Bilde L, Juhl HH, et al. Cost-effectiveness of the Danish smoking cessation interventions: subgroup analysis based on the Danish Smoking Cessation Database. Eur J Health Econ. 2006;7(4):255\u201364.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"70_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/02729890222062874","volume":"22","author":"DT Levy","year":"2002","unstructured":"Levy DT, Friend K. A simulation model of policies directed at treating tobacco use and dependence. Med Decis Making. 2002;22(1):6\u201317.","journal-title":"Med Decis Making"},{"issue":"6","key":"70_CR16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2165\/11589230-000000000-00000","volume":"29","author":"JG Xenakis","year":"2011","unstructured":"Xenakis JG, Kinter ET, Ishak KJ, et al. A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data. Pharmacoeconomics. 2011;29(6):497\u2013510.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"70_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","volume":"296","author":"D Gonzales","year":"2006","unstructured":"Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47\u201355.","journal-title":"JAMA"},{"issue":"1","key":"70_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","volume":"296","author":"DE Jorenby","year":"2006","unstructured":"Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56\u201363.","journal-title":"JAMA"},{"issue":"8","key":"70_CR19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/thx.2007.090647","volume":"63","author":"HJ Aubin","year":"2008","unstructured":"Aubin HJ, Bobak A, Britton JR, et al. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax. 2008;63(8):717\u201324.","journal-title":"Thorax"},{"issue":"2","key":"70_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","volume":"121","author":"NA Rigotti","year":"2010","unstructured":"Rigotti NA, Pipe AL, Benowitz NL, et al. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121(2):221\u20139.","journal-title":"Circulation"},{"issue":"3","key":"70_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1378\/chest.10-0865","volume":"139","author":"DP Tashkin","year":"2011","unstructured":"Tashkin DP, Rennard S, Hays JT, et al. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest. 2011;139(3):591\u20139.","journal-title":"Chest"},{"key":"70_CR22","unstructured":"Thun MJ. Data from Cancer Prevention Study II, 1982\u20131988 [provided by author \u2013 Michael J. Thun]"},{"key":"70_CR23","unstructured":"Shibuya K, Mathers C, Lopez A. Chronic obstructive pulmonary disease (COPD): consistent estimates of incidence, prevalence, and mortality by WHO region [DRAFT] [online]; 2001. http:\/\/www.who.int\/healthinfo\/statistics\/bod_copd.pdf (Accessed 8 Mar 2010)"},{"key":"70_CR24","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence of heart disease\u2014United States 2005 [online]; 2007. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5606a2.htm#fig (Accessed 8 Mar 2010)"},{"key":"70_CR25","unstructured":"Bureau of Labor Statistics (BLS). United States Bureau of Labor Statistics website [online]; 2010. http:\/\/www.bls.gov (Accessed May 2010)"},{"key":"70_CR26","unstructured":"Lloyd-Jones D. Prevalence of stroke by age and sex (NHANES: 2003\u20132006) [online]; 2010. http:\/\/circ.ahajournals.org\/cgi\/content\/full\/121\/7\/e46\/FIG36192671 (Accessed 8 Mar 2010)"},{"key":"70_CR27","doi-asserted-by":"crossref","unstructured":"Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001292","DOI":"10.1002\/14651858.CD001292.pub2"},{"issue":"2","key":"70_CR28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1037\/0278-6133.23.2.168","volume":"23","author":"DW Wetter","year":"2004","unstructured":"Wetter DW, Kenford SL, Welsch SK, et al. Prevalence and predictors of transitions in smoking behavior among college students. Health Psychol. 2004;23(2):168\u201377.","journal-title":"Health Psychol"},{"key":"70_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7547-6-1","volume":"6","author":"RT Hoogenveen","year":"2008","unstructured":"Hoogenveen RT, van Baal PH, Boshuizen HC, et al. Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: the role of time since cessation. Cost Eff Resour Alloc. 2008;6:1.","journal-title":"Cost Eff Resour Alloc"},{"key":"70_CR30","unstructured":"SEER. SEER Cancer Statistics Review 1975\u20132006. Cancer of the lung and bronchus (invasive) Table\u00a015.9. SEER incidence and U.S. death rates, age-adjusted and age-specific rates, by race and sex, years 2002\u20132006 [online]; 2006. http:\/\/seer.cancer.gov\/csr\/1975_2006\/results_single\/sect_15_table.09.pdf (Accessed 8 Mar 2010)"},{"issue":"7","key":"70_CR31","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/CIRCULATIONAHA.109.192667","volume":"121","author":"D Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics\u20142010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46\u2013215.","journal-title":"Circulation"},{"issue":"12","key":"70_CR32","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/01.STR.30.12.2523","volume":"30","author":"GR Williams","year":"1999","unstructured":"Williams GR, Jiang JG, Matchar DB, et al. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 1999;30(12):2523\u20138.","journal-title":"Stroke"},{"key":"70_CR33","unstructured":"SEER. SEER Cancer Statistics Review 1975\u20132006. U.S. complete prevalence counts, invasive cancers only, January 1, 2006 by age at prevalence. Table\u00a01.22 [online]; 2006. http:\/\/seer.cancer.gov\/csr\/1975_2006\/results_single\/sect_01_table.22_2pgs.pdf (Accessed 8 Mar 2010)"},{"key":"70_CR34","unstructured":"University of California Berkeley (USA), Max Planck Institute for Demographic Research (Germany). Human Mortality Database [online]; 2010. http:\/\/www.mortality.org or http:\/\/www.humanmortality.de (Accessed 8 Mar 2010)"},{"issue":"12","key":"70_CR35","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0895-4356(01)00405-X","volume":"54","author":"H Bronnum-Hansen","year":"2001","unstructured":"Bronnum-Hansen H, Jorgensen T, Davidsen M, et al. Survival and cause of death after myocardial infarction: the Danish MONICA study. J Clin Epidemiol. 2001;54(12):1244\u201350.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"70_CR36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1183\/09031936.00096108","volume":"33","author":"JP Torres de","year":"2009","unstructured":"de Torres JP, Cote CG, Lopez MV, et al. Sex differences in mortality in patients with COPD. Eur Respir J. 2009;33(3):528\u201335.","journal-title":"Eur Respir J"},{"issue":"1","key":"70_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.125.1.27","volume":"125","author":"CM Tammemagi","year":"2004","unstructured":"Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest. 2004;125(1):27\u201337.","journal-title":"Chest"},{"issue":"7514","key":"70_CR38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bmj.38510.458218.8F","volume":"331","author":"CD Wolfe","year":"2005","unstructured":"Wolfe CD, Smeeton NC, Coshall C, et al. Survival differences after stroke in a multiethnic population: follow-up study with the South London stroke register. BMJ. 2005;331(7514):431.","journal-title":"BMJ"},{"issue":"4","key":"70_CR39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0272989X06290496","volume":"26","author":"PW Sullivan","year":"2006","unstructured":"Sullivan PW, Ghushchyan V. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Med Decis Making. 2006;26(4):401\u20139.","journal-title":"Med Decis Making"},{"issue":"6","key":"70_CR40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2165\/00019053-200826060-00004","volume":"26","author":"P Howard","year":"2008","unstructured":"Howard P, Knight C, Boler A, et al. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers. Pharmacoeconomics. 2008;26(6):497\u2013511.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"70_CR41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thorax.58.5.388","volume":"58","author":"DM Mannino","year":"2003","unstructured":"Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58(5):388\u201393.","journal-title":"Thorax"},{"issue":"6","key":"70_CR42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2165\/00019053-200523060-00008","volume":"23","author":"M Spencer","year":"2005","unstructured":"Spencer M, Briggs AH, Grossman RF, et al. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. Pharmacoeconomics. 2005;23(6):619\u201337.","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"70_CR43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00019053-200119080-00007","volume":"19","author":"S Trippoli","year":"2001","unstructured":"Trippoli S, Vaiani M, Lucioni C, et al. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics. Pharmacoeconomics. 2001;19(8):855\u201363.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"70_CR44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0272989X9301300202","volume":"13","author":"DG Fryback","year":"1993","unstructured":"Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13(2):89\u2013102.","journal-title":"Med Decis Making"},{"issue":"2","key":"70_CR45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00019053-200523020-00005","volume":"23","author":"JW Hay","year":"2005","unstructured":"Hay JW, Sterling KL. Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease. Pharmacoeconomics. 2005;23(2):133\u201341.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"70_CR46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0028-3908(00)00003-4","volume":"39","author":"PW Duncan","year":"2000","unstructured":"Duncan PW, Lai SM, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology. 2000;39(5):835\u201341.","journal-title":"Neuropharmacology"},{"issue":"3","key":"70_CR47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00019053-200321030-00004","volume":"21","author":"TO Tengs","year":"2003","unstructured":"Tengs TO, Lin TH. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics. 2003;21(3):191\u2013200.","journal-title":"Pharmacoeconomics"},{"key":"70_CR48","unstructured":"Bureau of Labor Statistics (BLS). United States Bureau of Labor Statistics: Consumer Price Index website [online]; 2012. http:\/\/www.bls.gov\/cpi\/home.htm (Accessed Jun 2012)"},{"issue":"8","key":"70_CR49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2165\/11584620-000000000-00000","volume":"29","author":"AK O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan AK, Rubin J, Nyambose J, et al. Cost estimation of cardiovascular disease events in the US. Pharmacoeconomics. 2011;29(8):693\u2013704.","journal-title":"Pharmacoeconomics"},{"key":"70_CR50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/COPD.S13771","volume":"5","author":"AA Dalal","year":"2010","unstructured":"Dalal AA, Christensen L, Liu F, et al. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis. 2010;5:341\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"70_CR51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnci\/djq495","volume":"103","author":"AB Mariotto","year":"2011","unstructured":"Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010\u20132020. J Natl Cancer Inst. 2011;103(2):117\u201328.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR52","unstructured":"MAG Mutual Healthcare Solutions. Physicians\u2019 Fee and Coding Guide: 2012. MAG Mutual Healthcare Solutions Incorporated; 2012."},{"key":"70_CR53","unstructured":"Red Book Online. New York: Thomson-Reuters; 2012. http:\/\/www.redbook.com\/redbook\/online\/ (Accessed 8 Jun 2012)"},{"key":"70_CR54","unstructured":"Nicoderm CQ website [online]; 2012. http:\/\/www.nicodermcq.com\/Quit_Place_Dose.aspx (Accessed 8 Jun 2012)"},{"key":"70_CR55","doi-asserted-by":"crossref","unstructured":"Nicorette. Frequently asked questions [online]; 2012. http:\/\/www.nicorette.com\/Faqs.aspx#lnk16 (Accessed 1 Jun 2012)","DOI":"10.1002\/9781119208228.ch1"},{"key":"70_CR56","unstructured":"Nicotrol\u00ae NS (nicotine nasal spray) prescribing information [online]; 2012. http:\/\/media.pfizer.com\/files\/products\/uspi_nicotrol.pdf (Accessed 5 Jun 2012)"},{"key":"70_CR57","unstructured":"Nicorette\u00ae Lozenge website [online]; 2012. http:\/\/www.commitlozenge.com\/Quit_Place_Dose.aspx (Accessed 5 Jun 2012)"},{"key":"70_CR58","unstructured":"Department of Health and Human Services: Centers for Medicare and Medicaid Services. Tobacco-Use Cessation Counseling Services. Baltimore: Centers for Medicare and Medicaid Services; 2012. https:\/\/www.cms.gov\/Outreach-and-Education\/Medicare-Learning-Network-MLN\/MLNProducts\/downloads\/smoking.pdf (Accessed Feb 2012)"},{"key":"70_CR59","unstructured":"Office on Smoking and Health (US). Women and smoking: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention (US); 2001. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK44303\/ [Accessed Jun 2013]"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-013-0070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40273-013-0070-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-013-0070-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:44:16Z","timestamp":1715615056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40273-013-0070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,3]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s40273-013-0070-5","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,3]]}}}